应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
01801 信达生物
未开盘 10-16 16:08:16
89.050
+1.300
+1.48%
最高
92.450
最低
88.000
成交量
969.38万
今开
91.250
昨收
87.750
日振幅
5.07%
总市值
1,556亿
流通市值
1,556亿
总股本
17.47亿
成交额
8.76亿
换手率
0.55%
流通股本
17.47亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
异动解读｜信达生物盘中上涨3.53%，创新药板块回暖叠加临床利好提振情绪
行情直击 · 10-16
异动解读｜信达生物盘中上涨3.53%，创新药板块回暖叠加临床利好提振情绪
【券商聚焦】中信建投：ESMO中国研究入选创新高 梳理医药细分板块机会
金吾财讯 · 10-16
【券商聚焦】中信建投：ESMO中国研究入选创新高 梳理医药细分板块机会
【券商聚焦】中信建投：AI重塑药物研发 2035年全球市场有望破460亿美元
金吾财讯 · 10-15
【券商聚焦】中信建投：AI重塑药物研发 2035年全球市场有望破460亿美元
小摩：中国生物科技ESMO催化剂可验证本土创新 首选科伦博泰生物及信达生物
新浪港股 · 10-14
小摩：中国生物科技ESMO催化剂可验证本土创新 首选科伦博泰生物及信达生物
港股三大指数走强 恒生科技指数上涨1.61% 小米集团-W（01810）涨超5%
金吾财讯 · 10-14
港股三大指数走强 恒生科技指数上涨1.61% 小米集团-W（01810）涨超5%
异动解读｜信达生物盘中下跌3.32%，创新药板块回调拖累情绪
行情直击 · 10-14
异动解读｜信达生物盘中下跌3.32%，创新药板块回调拖累情绪
小摩：中国生物科技ESMO催化剂可验证本土创新 首选科伦博泰生物(06990.HK)信达生物(01801.HK)
智通财经 · 10-13
小摩：中国生物科技ESMO催化剂可验证本土创新 首选科伦博泰生物(06990.HK)信达生物(01801.HK)
港股开盘向好 恒指高开0.65% 信达生物（01801）涨1.89%
金吾财讯 · 10-09
港股开盘向好 恒指高开0.65% 信达生物（01801）涨1.89%
【券商聚焦】中泰国际：多家药企将公布重要数据 推荐创新药与CXO龙头
金吾财讯 · 10-09
【券商聚焦】中泰国际：多家药企将公布重要数据 推荐创新药与CXO龙头
港股异动 | 创新药概念股午后跌幅扩大 歌礼制药-B(01672.HK)跌超10% 信达生物(01801.HK)跌近4%
智通财经 · 10-08
港股异动 | 创新药概念股午后跌幅扩大 歌礼制药-B(01672.HK)跌超10% 信达生物(01801.HK)跌近4%
异动解读｜信达生物盘中下跌3.18%，生物科技板块整体承压
行情直击 · 10-08
异动解读｜信达生物盘中下跌3.18%，生物科技板块整体承压
信达生物发布2026年9月股份变动月报表，已发行股份增至1,746,918,350股
公告速递 · 10-07
信达生物发布2026年9月股份变动月报表，已发行股份增至1,746,918,350股
异动解读｜信达生物盘中下跌3.07%，生物科技板块承压
行情直击 · 10-07
异动解读｜信达生物盘中下跌3.07%，生物科技板块承压
【券商聚焦】国金证券：行业有望迎业绩与估值戴维斯双击，创新药板块底部配置价值凸显
金吾财讯 · 10-05
【券商聚焦】国金证券：行业有望迎业绩与估值戴维斯双击，创新药板块底部配置价值凸显
异动解读｜信达生物盘中下跌3.47%，报92.8港元
行情直击 · 10-02
异动解读｜信达生物盘中下跌3.47%，报92.8港元
异动解读｜信达生物盘中上涨3.18%，中报业绩强劲叠加新适应症获批
行情直击 · 09-30
异动解读｜信达生物盘中上涨3.18%，中报业绩强劲叠加新适应症获批
信达生物2026年中期营收86.18亿元，经调整净利润17.04亿元
公告速递 · 09-29
信达生物2026年中期营收86.18亿元，经调整净利润17.04亿元
信达生物(01801)：捷帕力®(匹妥布替尼)在中国获批慢性淋巴细胞白血病(CLL)╱小淋巴细胞淋巴瘤(SLL)全线治疗新适应症
智通财经 · 09-28
信达生物(01801)：捷帕力®(匹妥布替尼)在中国获批慢性淋巴细胞白血病(CLL)╱小淋巴细胞淋巴瘤(SLL)全线治疗新适应症
港股三大指数早盘涨跌不一 恒生指数半日涨0.64% 网易（09999）涨4.42%
金吾财讯 · 09-28
港股三大指数早盘涨跌不一 恒生指数半日涨0.64% 网易（09999）涨4.42%
异动解读｜信达生物盘中下跌3.31%，报96.4港元
行情直击 · 09-28
异动解读｜信达生物盘中下跌3.31%，报96.4港元
加载更多
公司概况
公司名称：
信达生物
所属市场：
SEHK
上市日期：
--
主营业务：
信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢（CVM）、自身免疫及眼科等重大疾病创新药物的投资控股公司。药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。该公司的主要产品包括达伯舒（信迪利单抗注射液）、达攸同（贝伐珠单抗注射液）、苏立信（阿达木单抗注射液）、达伯华（利妥昔单抗注射液）、达伯坦（佩米替尼片）等。该公司主要在中国国内和海外市场开展业务。
发行价格：
--
{"stockData":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"信达生物","latestPrice":89.05,"timestamp":1792138096004,"preClose":87.75,"halted":0,"volume":9693837,"delay":0,"changeRate":0.014814814814814782,"floatShares":1747000000,"shares":1747000000,"eps":0.469999,"marketStatus":"未开盘","change":1.3,"latestTime":"10-16 16:08:16","open":91.25,"high":92.45,"low":88,"amount":875889219,"amplitude":0.050712,"askPrice":89.05,"askSize":46000,"bidPrice":89,"bidSize":4500,"shortable":3,"etf":0,"ttmEps":0.803379,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":0,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":87.75,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":1.1270259602946482,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.4826,"impliedVolPercentile":0.4919},"requestUrl":"/m/hq/s/01801","defaultTab":"news","newsList":[{"id":"1116227131","title":"异动解读｜信达生物盘中上涨3.53%，创新药板块回暖叠加临床利好提振情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1116227131","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116227131?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:38","pubTimestamp":1792114738,"startTime":"0","endTime":"0","summary":"10月16日，信达生物盘中上涨3.53%，报91.25港元，成交额1.63亿港元。消息面上，公司此前公布信必敏非活动性甲状腺眼病Ⅲ期临床研究RESTORE-3达成主要终点，显示其综合产品线持续取得进展；同时，摩根大通近日将信达生物列为中国生物科技ESMO催化剂首选之一，强化了市场对其本土创新与国际化潜力的关注。从基本面看，公司中期营收86.18亿元，同比增长44.8%，经调整净利润17.04亿元，同比增长40.5%，产品收入增长56.7%，盈利能力与商业化兑现为股价提供支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"信达生物盘中上涨，临床利好提振情绪","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675546035","title":"【券商聚焦】中信建投：ESMO中国研究入选创新高 梳理医药细分板块机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2675546035","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675546035?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:27","pubTimestamp":1792114033,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券表示，本周制药行业表现一般，2026 ESMO LBA中国研究入选创新高，恒瑞医药、康方生物、艾力斯等企业的管线迎来新进展。医疗器械及服务板块低值耗材表现较好，多受个股事件催化，科技概念标的调整，港股回购活跃；短期关注招标改善和集采出清，中长期看创新、出海、并购。中药板块跑赢申万医药及大盘，关注红利、创新及“四同药品”、中成药集采政策。生物制品板块跑输医药指数及大盘，AI制药、mRNA肿瘤疫苗概念股回调；南北方ILI%均环比降低，南方检测阳性率提升、北方降低。医药商业板块跑赢申万医药及大盘，药店关注三季度前瞻及集采进药店，流通关注回款及三季度前瞻。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993829","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","BK1610","LU0979878070.USD","02142","LU0052750758.USD","LU0634319403.HKD","06160","LU0228659784.USD","LU0140636845.USD","01177","09939","601066","LU0072913022.USD","159938","LU0326950275.SGD","LU0359201612.USD","01801","02269","01877","LU1951186391.HKD","SG9999002562.SGD","KURE","IE00BZ08YR35.GBP","BK1500","LU1226287792.SGD","09688","LU0181495838.USD","LU0823426480.USD","LU1251922891.USD","SG9999011746.SGD","LU2476274720.SGD","KCE","LU0540923850.HKD","LU0348827113.USD","BK1515","02616","LU1226287875.USD","06185","LU0501845795.SGD","LU0819121731.USD","LU1242518857.USD","LU0417516902.SGD","BK1583","09926","LU1969619763.USD","BK1141","LU0314109678.HKD","LU0128526141.USD","LU0348767384.USD","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675376082","title":"【券商聚焦】中信建投：AI重塑药物研发 2035年全球市场有望破460亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675376082","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675376082?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:00","pubTimestamp":1792026019,"startTime":"0","endTime":"0","summary":"AI深度介入靶点识别、分子设计等药物研发环节，破解传统制药高投入、长周期难题。报告测算，全球AI制药市场2025年规模约24.9亿美元，2035年有望突破460亿美元，CAGR超33%，国内市场具备高增长潜力；科技巨头、药企、CXO等多方入局，海内外多家头部企业完成平台搭建与商业化验证。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993729","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","SG9999002562.SGD","VTHR","IE00B031HY20.USD","LU0516423174.USD","LU0456827905.SGD","LU0516422440.USD","AIPO","LU0029874061.USD","LU2778985437.USD","BK1576","LU0128526141.USD","AGIX","01093","LU0979878070.USD","LU0516422952.EUR","09995","LU1008478684.HKD","01877","BK1141","LU0348825331.USD","LU0856984785.SGD","02269","LU0588546209.SGD","BK1588","06185","LU0501845795.SGD","LU0051755006.USD","KCE","02616","02142","QTOC","ARTY","LU0128522744.USD","LU0052750758.USD","LU0326950275.SGD","06160","09688","LU1152091754.HKD","CHAT","KURE","LU0456846285.SGD","LU2242644610.SGD","BK1500","09926","IBBJ","IE00BZ08YS42.EUR","01801","601066","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675152853","title":"小摩：中国生物科技ESMO催化剂可验证本土创新 首选科伦博泰生物及信达生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2675152853","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675152853?lang=zh_cn&edition=full","pubTime":"2026-10-14 14:30","pubTimestamp":1791959400,"startTime":"0","endTime":"0","summary":"模拟交易客户端10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！该行覆盖的逾20只中国生物科技股上周下跌4.4%，跑输恒生指数升1.8%。ESMO论文摘要预计于10月18日美东时间晚上6时发布，海报预计于10月23日上线，ESMO会议于10月23至27日举行。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-10-14/doc-iniveqvs1150233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2237443465.HKD","LU0640476718.USD","LU0942090050.USD","LU1366192091.USD","LU0211327993.USD","LU0203345920.USD","LU0943347566.SGD","VFH","LU0157215616.USD","UYG","LU0868494708.USD","LU1267930490.SGD","LU0251132253.USD","BK1610","IYG","XLF","TRUF","LU0106261372.USD","LU0196878994.USD","LU0267386448.USD","LU1363072403.SGD","01801","LU1119994496.HKD","LU2505996509.AUD","JPMO","LU2552382132.HKD","BK4566","LU0211328371.USD","IE00BHPRN162.USD","06990","03069","IXG","FTXO","IE00BKDWB100.SGD","LU0211326839.USD","IE00BKVL7J92.USD","TFNS","LU2756315318.SGD","LU0787776722.HKD","FNCL","IE00B1BXHZ80.USD","JPO","KURE","LU2242644610.SGD","KBWB","LU0417517546.SGD","BK1589","LU2462157665.USD","IE00B775SV38.USD","IYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675397404","title":"港股三大指数走强 恒生科技指数上涨1.61% 小米集团-W（01810）涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675397404","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675397404?lang=zh_cn&edition=full","pubTime":"2026-10-14 12:14","pubTimestamp":1791951289,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数走强，截至午间收盘，恒生指数上涨0.16%；国企指数上涨0.25%；恒生科技指数上涨1.61%。板块方面，PCB概念早盘走强，截至午间收盘，涨幅略有收窄，金安智能涨1.96%，中国建材涨1.47%，胜宏科技涨1.45%，景旺电子涨0.91%，广合科技涨0.54%。机器人概念走强，截至午间收盘，小米集团-W涨5.51%，德昌电机控股涨4.81%，梅卡曼德机器人涨3.50%，阿里巴巴-W涨3.45%，小鹏集团-W涨3.33%。个股方面，名创优品半日涨3.98%。爱芯元智半日涨8.95%。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993676","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","LU0149534421.HKD","LU0385154629.USD","IE00B97KM107.HKD","LU0128522157.USD","LU1969619763.USD","LU2045819591.USD","IE00B0169N27.USD","HSTECH","LU1051768304.USD","LU0856984785.SGD","LU0348825331.USD","LU1224444064.USD","HXXD.SI","LU0620787316.HKD","LU0862451753.SGD","LU2097828631.EUR","LU0228367735.SGD","BK1142","LU0737861772.HKD","03033","BK1591","LU0540923850.HKD","LU2476274720.SGD","LU0210527791.USD","LU2087589342.USD","LU1008478684.HKD","LU0396098781.USD","LU1720051108.HKD","LU1868837722.USD","LU0327786744.USD","06160","LU0067412154.USD","LU0227179875.USD","LU1048596156.SGD","LU0588545490.SGD","LU0054450605.USD","LU0320764243.SGD","BK1193","02319","IE00B067MR52.USD","SG9999001069.SGD","LU0029875118.USD","LU0823397285.USD","LU0054237671.USD","LU0886674414.USD","LU2488822045.USD","HK0000306701.USD","09896","LU0594300179.USD","LU1880398554.USD","LU0132412106.USD","CIADY","01093","LU0791591158.USD","03067","BK1258","300476","LU1770036033.HKD","LU0384037296.USD","03115","LU1770034418.SGD","LU0441854154.USD","SG9999001051.SGD","SG9999012728.SGD","LU0651946864.USD","HK0000320264.USD","SG9999012736.USD","IE0032431581.USD","LU1211504680.USD","SG9999001903.USD","LU2125910500.SGD","LU1166156734.SGD","LU0831103253.SGD","HMTD.SI","LU0651947912.USD","LU1196710864.SGD","LU0918141887.USD","82800","09088","BK1539","LU0348788117.USD","KWEB","LU0898667661.SGD","SOCL","LU1064130708.USD","03032","IE0008368411.USD","HK0000286598.CNH","LU1328277881.USD","LU0106959298.USD","02476","BK1135","SG9999001226.SGD","LU0235996351.USD","IE00B5MMRT66.SGD","METmain","LU0348827113.USD","LU0164939612.USD","LU0084288322.USD","513600","MNSO","HK0000306685.HKD","LU0348814723.USD","LU0320764599.SGD","LU0287142896.SGD","LU1303224171.USD","LU0359201612.USD","LU0589944569.HKD","LU0630378429.USD","BK1608","LU1655091459.SGD","IE00BYQNZ168.SGD","LU1328615791.USD","LU0127658192.USD","LU2929501877.USD","LU0259732245.USD","LU0821914370.USD","LU1951186391.HKD","LU1366334578.USD","LU1481107354.HKD","BABA","LU0572944931.SGD","BK1191","LU0823038988.USD","LU1188198961.HKD","LU0516422366.SGD","LU2148510915.USD","LU0797268264.HKD","SG9999012744.USD","LU0117841782.USD","09988","LU0594300419.USD","LU1226288253.USD","LU1568876335.HKD","LU0345775950.USD","LU0051755006.USD","LU0326950275.SGD","LU0543330483.HKD","LU1152091168.USD","LU0683595622.HKD","LU0048580855.USD","LU0737861699.HKD","LU0140636845.USD","SG9999002562.SGD","LU0128522744.USD","LU0143863784.USD","LU2097828557.USD","LU0082770016.SGD","LU0315179316.USD","07200","BK1517","TTNDY","BK1501","LU0577902454.USD","LU0890818403.SGD","LU0348816934.USD","BK1523","BK1170","LU0463099449.HKD","BK1095","LU0417516738.SGD","LU1366334651.USD","BK1229","LU0205439572.USD","LU1981816686.USD","BK1586","LU0499858438.USD","LU0320764755.SGD","LU1719994722.HKD","LU1102505762.USD","KSTmain","LU0130103400.USD","LU0702159699.USD","LU0541501648.USD","LU0650527681.SGD","BK1502","IE00BYTNYN87.SGD","BK1575","00179","HHImain","IE00B031HY20.USD","IE0032834883.USD","02837","LU0593848301.USD","SGXZ86797644.SGD","LU1064131003.USD","LU1720051017.SGD","LU0516423174.USD","00669","LU1282649810.SGD","LU0588545904.SGD","LU0117844026.USD","LU0516422952.EUR","BK1563","LU0049853897.USD","LU0819121731.USD","BK1584","LU0531971595.HKD","SG9999001689.USD","LU0608807433.USD","IE0009570106.USD","LU0918141705.HKD","LU2476274308.USD","LU0293314216.USD","LU0417516571.SGD","LU1046422090.SGD","KURE","LU0251143458.SGD","IE00BZ08YS42.EUR","LU0572939691.SGD","ONC","LU0828238088.HKD","LU0471298777.SGD","BK1161","XPEV","LU0348735423.USD","LU0210526637.USD","IE00B031J352.USD","LU0708995583.HKD","BK1607","LU1831875114.USD","SG9999003461.SGD","LU0708995153.HKD","LU1048484197.HKD","HK0000352291.HKD","LU1960683339.HKD","HLPPY","LU2039709279.SGD","601628","LU1044876610.USD","03423","LU0577902371.SGD","LU1880383440.USD","SBHMY","LU0499858602.USD","LU0196878994.USD","03417","BK1597","LU0449509016.USD","LU0149721374.USD","SG9999011746.SGD","LU0043850808.USD","LU1808992512.USD","LU0607220059.USD","LU0634319403.HKD","IE00B543WZ88.USD","LU0509642566.USD","603228","LU1102505929.USD","LU0431992006.USD","LU0456846285.SGD","SG9999002950.SGD","LU0823426308.USD","BK1249","LU0828237940.HKD","LU0648000940.SGD","HK0000320223.HKD","BK1550","LU0254981946.USD","LU1282651121.HKD","LU3063872942.SGD","SG9999006597.SGD","LU2328871848.SGD","JEHLY","BK1144","81810","LU1226287875.USD","01177","LU0642271901.SGD","LU0611395673.USD","LU0823413587.USD","01810","02800","LU1568876251.USD","LU0096374516.USD","LU0326948709.USD","LU2097828714.EUR","01801","LU0561508036.HKD","LU1807302812.USD","SG9999004220.SGD","00101","001389","LU0128526141.USD","LU0307460666.USD","LU0052750758.USD","LU0359201885.HKD","LU0488056044.USD","LU0501845795.SGD","LU1868837565.USD","SG9999012710.SGD","SG9999006514.SGD","BK1555","ALBmain","07500","BKF","LU0862451837.USD","BK1233","SGXZ62798434.SGD","BK1610","LU0831093199.SGD","LU0823041008.USD","LU0370786039.SGD","BK1587","LU0011963245.USD","688235","LU1282649067.USD","LU2187417386.USD","LU1023057109.AUD","SG9999014674.SGD","01989","LU1993786604.SGD","LU0165289439.USD","LU0181495838.USD","BK1594","DRGN","LU1051769294.HKD","LU0061477393.USD","LU0328353924.USD","LU1868838027.USD","LU0455707207.USD","LU0577902538.SGD","03228","IE00BF5LJ272.USD","LU1675838814.USD","IE00B0JY6N72.USD","LU0048597586.USD","LU2778985437.USD","LU0873338254.USD","IE00B29SXG58.USD","07552","LU0264606111.USD","BK1588","LU0784639295.USD","IE0031814852.USD","LU0048388663.USD","LU2177674079.SGD","00567","LU0675040207.SGD","MHImain","LU2152927971.USD","LU0871576103.HKD","HK0000352382.USD","LU1048588211.SGD","83115","LU0228659784.USD","LU0164872284.USD","BK1601","IE00BZ08YT58.USD","LU0072913022.USD","LU0588546209.SGD","LU1282648689.USD","LU1880383366.USD","LU1206782309.USD","LU0269904917.USD","LU2293587155.HKD","LU1515016050.SGD","IE0008368304.USD","BK1184","LU0197773160.USD","MCHmain","IE00B0169L03.USD","LU0329678337.USD","LU1242518857.USD","LU0106259558.USD","LU0762542818.HKD","LU1734074674.USD","LU0214875030.USD","LU0541502299.USD","LU0477156797.USD","LU0633140560.USD","09115","LU0608807946.USD","LU0449515922.USD","00600","IE0008368742.USD","LU0169518387.USD","LU2097828805.USD","BK1119","LU0819123356.HKD","LU0700851271.USD","LU0865486749.SGD","03419","LU0229945570.USD","LU0516422440.USD","LU0261947096.USD","LU0630378692.HKD","LU1316542783.SGD","BK1615","LU1282649141.HKD","LU1688375341.USD","LU0197773673.USD","03323","BK1506","LU0640798160.USD","LU1242518931.SGD","LU1323998911.USD","LU2226246903.HKD","LU0605514214.HKD","LU0672654166.SGD","LU1642822792.SGD","LU0348767384.USD","LU0173614495.USD","LU0348784397.USD","SG9999001093.SGD","IE0008369823.USD","LU0516423091.SGD","IE00B3M56506.USD","LU0572940350.SGD","03690","03088","LU0029874061.USD","LU0348805143.USD","LU1226287529.USD","LU1044874839.SGD","LU0348766576.USD","09067","BK1604","LU0878005551.USD","LU0502904849.HKD","SG9999002828.SGD","LU0868486357.SGD","LU1439103000.SGD","CXSE","LU1961090484.USD","09615","LU1119993845.HKD","BK1583","89988","LU0029874905.USD","LU2357305700.SGD","LU0348783662.USD","02628","LU1813983027.USD","LU0231483743.USD","LU1504937902.USD","LU0251144936.SGD","LU1105468828.SGD","LU1810669033.SGD","LU0039217434.USD","LU1226287792.SGD","LU2257852520.SGD","IE0003895053.USD","IE00BZ08YR35.GBP","LU1251922891.USD","SGXZ90724238.SGD","LU1282651048.USD","LU0106252389.USD","LU0979878070.USD","LU1115378108.SGD","BK1183","LU0762541174.USD","LU0143863198.USD","LU0823426480.USD","LU1548497426.USD","LU0531970944.HKD","02833","LU0791590937.USD","LU2399975544.HKD","LU0345776255.USD","LU1226288170.HKD","XIACY","IE00B12V2V27.USD","LU2125910849.SGD","09868","IE00BPRC5H50.USD","LU0047713382.USD","07226","LU1044875133.USD","LU2351347302.SGD","LU0348783233.USD","SG9999000459.SGD","HK0000165453.HKD","LU0163747925.USD","LU0231459107.USD","LU0164865239.USD","LU2449936058.SGD","LU0588545730.USD","CBUMY","LU0130518102.USD","LU0702159343.USD","LU0648948544.HKD","LU0417516902.SGD","LU0314109678.HKD","LU0828237510.HKD","BK1237","LDEM","HK0000151867.HKD","LU2097829019.USD","LU1201861165.SGD","BK1216","IE00BMPRXN33.USD","LU0359202008.SGD","IE00BMPRXR70.SGD","81024","LU0244354667.USD","LU0577902298.EUR","LU0762540952.USD","BK1246","LU0211977185.USD","LU0329678170.USD","LU1769817096.USD","LU1769817179.HKD","LU0315178854.USD","LU0823039010.USD","BK1503","LU2008162690.USD","IE00B031HW06.USD","LU1956131251.USD","BK1553","BK1515","01024","LU0543330566.HKD","LU0633140727.USD","BK1500","LU0261950983.USD","HK0000107257.USD","LU0823397103.USD","LU0469268626.HKD","BK1590","LU2294711473.HKD","LU0456827905.SGD","LU0823040885.USD","BK1521","BK1163","BK1589","LU0823413660.USD","LU0577902611.USD","LU1152091754.HKD","HSI","HBBD.SI","LU2097828474.EUR","LU1224709979.USD","SG9999002463.SGD","LU0072462343.USD","LU0164880469.USD","LU0877626530.USD","BK1209","FDNI","LU0082770016.USD","MPNGY","LU2242644610.SGD","LU0880133367.SGD","BK1618","SG9999000327.SGD","03037","07300","LU1880398471.USD","LU1720050803.USD","IE0034224299.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142662648","title":"异动解读｜信达生物盘中下跌3.32%，创新药板块回调拖累情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1142662648","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142662648?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:36","pubTimestamp":1791941813,"startTime":"0","endTime":"0","summary":"10月14日，信达生物盘中下跌3.32%，报89.0港元，成交额5881.09万港元。近端消息面上，机构近期持续强调ESMO将成为中国创新药重要催化窗口，小摩最新点出中国生物科技ESMO催化剂可验证本土创新，并将信达生物列为首选之一；但板块层面此前已出现创新药概念股跌幅扩大，显示在大会数据落地前后，资金博弈加剧、板块波动放大。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"信达生物盘中下跌，创新药板块回调拖累情绪","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675311143","title":"小摩：中国生物科技ESMO催化剂可验证本土创新 首选科伦博泰生物(06990.HK)信达生物(01801.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675311143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675311143?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:50","pubTimestamp":1791877833,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1969619763.USD","LU0149534421.HKD","LU2097828631.EUR","LU2097828805.USD","BK1610","LU2242644610.SGD","LU0455707207.USD","LU0244354667.USD","LU0607220059.USD","LU1188198961.HKD","LU2328871848.SGD","LU1831875114.USD","HK0000165453.HKD","LU0326950275.SGD","BK1589","LU0463099449.HKD","LU2097828474.EUR","LU2488822045.USD","BK1161","BK1583","LU0196878994.USD","KURE","01801","LU2097828557.USD","LU2097828714.EUR","03069","06990","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674884855","title":"港股开盘向好 恒指高开0.65% 信达生物（01801）涨1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674884855","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674884855?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:25","pubTimestamp":1791509107,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘向好，恒指高开0.65%，国企指数高开0.58%，恒生科技指数高开0.29%。截至2026年9月30日止9个月，集团的激光雷达产品销量约为131.48万台，当中，用于ADAS应用的激光雷达产品及用于机器人及其他的激光雷达产品销量分别约为88.7万台及42.78万台。港股昨日跟随外围向下，指数再度失守24,000点水平，尾市跌幅进一步加大，整体成交明显增加。债息继续成为市场关注重点，短期困扰大市表现，预料指数继续在23,500至24,500点水平徘徊。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993358","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02833","07500","LU2242644610.SGD","01801","LU1831875114.USD","LU2488822045.USD","07300","83115","BK1583","BK1589","07200","HHImain","03115","LU0455707207.USD","LU0326950275.SGD","03419","LU0149534421.HKD","LU2097828805.USD","LU1188198961.HKD","LU2097828714.EUR","HSTECH","02800","KURE","MCHmain","82800","LU0607220059.USD","09115","03037","LU1969619763.USD","BK1161","HK0000165453.HKD","HSI","LU0244354667.USD","LU2097828474.EUR","LU2097828557.USD","LU0463099449.HKD","LU2328871848.SGD","513600","LU0502904849.HKD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674892318","title":"【券商聚焦】中泰国际：多家药企将公布重要数据 推荐创新药与CXO龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2674892318","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674892318?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:38","pubTimestamp":1791506310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际表示，多家创新药企业将于10月下旬ESMO公布重要临床数据。ESMO是欧洲最具盛名和影响力的肿瘤学会议，LBA是最高级别的研究成果展示，因此ESMO公布的LBA在医药行业广受关注。中国企业入选的LBA中，有四项入选最高级别的主席研讨会。该机构认为，以上情况表明中国创新药研发能力在海外广受认可，因此创新药板块值得继续关注。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993342","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","06978","LU1008478684.HKD","SG9999002463.SGD","IE00BZ08YR35.GBP","IE0008369823.USD","LU1242518931.SGD","02268","01177","02359","BK1521","CXO","MEDX","BK1191","WX","02269","LU0067412154.USD","LU1960683339.HKD","IBBQ","LU1831875114.USD","LU2399975544.HKD","IE00B5MMRT66.SGD","06821","01093","09926","LU0348783233.USD","LU0348767384.USD","LU0348827113.USD","LU0307460666.USD","LU0327786744.USD","LU0314109678.HKD","159992","00013","LU2097828557.USD","LU0572944931.SGD","LU2488822045.USD","LU0561508036.HKD","KCE","KURE","LNGR","01801","BK1500","LU0708995153.HKD","LU0823426308.USD","LU2125910500.SGD","LU1688375341.USD","LU0320764599.SGD","LU2097828714.EUR","LU0149534421.HKD","LU0029874905.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2673896025","title":"港股异动 | 创新药概念股午后跌幅扩大 歌礼制药-B(01672.HK)跌超10% 信达生物(01801.HK)跌近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673896025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673896025?lang=zh_cn&edition=full","pubTime":"2026-10-08 14:01","pubTimestamp":1791439309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2242644610.SGD","LU2097828631.EUR","BK1515","01801","LU0607220059.USD","LU0326950275.SGD","HK0000165453.HKD","BK1191","LU0455707207.USD","LU2328871848.SGD","01477","LU1831875114.USD","LU0463099449.HKD","LU0502904849.HKD","LU2097828474.EUR","LU0149534421.HKD","LU1969619763.USD","LU2097828714.EUR","LU0244354667.USD","LU2488822045.USD","01672","LU2097828557.USD","BK1583","BK1574","BK1161","06978","BK1589","KURE","LU1188198961.HKD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173871522","title":"异动解读｜信达生物盘中下跌3.18%，生物科技板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1173871522","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173871522?lang=zh_cn&edition=full","pubTime":"2026-10-08 10:51","pubTimestamp":1791427897,"startTime":"0","endTime":"0","summary":"10月8日，信达生物盘中下跌3.18%，报94.45港元，成交额4.11亿港元。消息面上，公司前一日公布的9月股份变动月报表显示已发行股份增至17.47亿股，期间并无回购发生。同时，生物科技板块整体延续弱势，康方生物、百济神州等权重个股同步走低。信达生物制药主要从事研发、生产及销售治疗肿瘤、心血管及代谢、自身免疫及眼科等重大疾病创新药物，药物形式涵盖单克隆抗体、多特异性抗体、免疫细胞因子、ADC、细胞治疗及小分子药物等。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"信达生物盘中下跌，生物科技板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186407801","title":"信达生物发布2026年9月股份变动月报表，已发行股份增至1,746,918,350股","url":"https://stock-news.laohu8.com/highlight/detail?id=1186407801","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186407801?lang=zh_cn&edition=full","pubTime":"2026-10-07 17:51","pubTimestamp":1791366685,"startTime":"0","endTime":"0","summary":"信达生物于2026年10月7日公布了截至2026年9月30日的股份变动月报表。报告显示，公司本月末的法定/注册股本仍为5,000,000,000股普通股，面值每股0.00001美元，法定/注册股本总额维持在50,000美元，未发生变动。本月末已发行股份总数由1,744,845,102股增加至1,746,918,350股，较上月增长2,073,248股。根据公告，期内并未发生公司股份回购或注销情况。2024年股份计划则在本月新增授出59,757股权，另有376,800份已失效。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160786164","title":"异动解读｜信达生物盘中下跌3.07%，生物科技板块承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1160786164","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160786164?lang=zh_cn&edition=full","pubTime":"2026-10-07 10:12","pubTimestamp":1791339173,"startTime":"0","endTime":"0","summary":"10月7日，信达生物盘中下跌3.07%，报96.3港元，成交额1.6亿港元。信达生物所在的生物科技行业中，整体表现偏弱，个股中，康方生物跌3.35%，剂泰科技-P跌7.34%，百济神州跌1.36%，三生制药跌4.12%，康希诺生物跌7.39%。信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢、自身免疫及眼科等重大疾病创新药物的投资控股公司。药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物、细胞治疗及小分子药物等。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673792787","title":"【券商聚焦】国金证券：行业有望迎业绩与估值戴维斯双击，创新药板块底部配置价值凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2673792787","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673792787?lang=zh_cn&edition=full","pubTime":"2026-10-05 08:50","pubTimestamp":1791161445,"startTime":"0","endTime":"0","summary":"随着后续管线商业化兑现、全球创新价值链话语权提升，行业有望迎来业绩与估值的戴维斯双击，创新药板块底部配置价值凸显。中国研究占全体大会核心LBA总量的1/3，这标志着中国肿瘤创新研发已深度融入全球研发体系，成为驱动全球肿瘤诊疗升级的重要力量，持续利好国内创新药企国际化发展与临床价值兑现。2026 ESMO已公布LBA标题，29项LBA的试验药物由中国药企原研或参与开发，涉及约20家企业，其中5项进入主席研讨会。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992996","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","LU1226288253.USD","LU0315179316.USD","LU0856984785.SGD","02269","LU0359202008.SGD","06160","LU0455707207.USD","01177","LU0211977185.USD","LU0516422952.EUR","BK1610","IE0008368742.USD","LU1794554557.SGD","LU2242644610.SGD","MEDX","01877","LU0244354667.USD","06185","HK0000165453.HKD","LU1328277881.USD","KCE","BK1515","BK1583","LU0823426480.USD","LU1226287875.USD","LU1807302812.USD","LU0823426308.USD","LU2399975544.HKD","IBBQ","09688","02142","06978","LU0043850808.USD","KURE","BK0201","LNGR","LU0314109678.HKD","600109","LU0052750758.USD","02616","BK1161","LU0540923850.HKD","01801","09995","01093","09926","IE00BPRC5H50.USD","LU1242518931.SGD","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102752692","title":"异动解读｜信达生物盘中下跌3.47%，报92.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102752692","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102752692?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:35","pubTimestamp":1790904939,"startTime":"0","endTime":"0","summary":"10月2日，信达生物盘中下跌3.47%，报92.8港元/股，成交额8706.9万港元。信达生物所在的生物科技行业中，板块整体承压明显，个股中，百济神州跌7.1%，三生制药跌5.55%，科伦博泰生物跌4.52%，复宏汉霖跌3.07%，康方生物跌2.58%。信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢、自身免疫及眼科等重大疾病创新药物的投资控股公司，药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140223410","title":"异动解读｜信达生物盘中上涨3.18%，中报业绩强劲叠加新适应症获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1140223410","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140223410?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:39","pubTimestamp":1790735948,"startTime":"0","endTime":"0","summary":"9月30日，信达生物盘中上涨3.18%，报99.0港元/股，成交额5.28亿港元。消息面上，公司近日公布中期财报，上半年实现营收86.18亿元人民币，同比增长44.8%；经调整净利润17.04亿元，同比增长40.5%；产品收入82.01亿元，同比大增56.7%，占总收入逾95%。经营活动现金净额35.88亿元，同比增幅超10倍，盈利质量显著提升。多家国际投行近期上调目标价并维持买入评级，市场情绪偏暖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"信达生物盘中上涨，中报业绩与新适应症双驱动","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176595973","title":"信达生物2026年中期营收86.18亿元，经调整净利润17.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176595973","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176595973?lang=zh_cn&edition=full","pubTime":"2026-09-29 16:49","pubTimestamp":1790671747,"startTime":"0","endTime":"0","summary":"信达生物公布2026年中期财报。财报显示，报告期内营收86.18亿元，同比增长44.8%。经调整净利润17.04亿元，同比增长40.5%。Non-GAAP毛利率为85.5%，较上年同期的86.8%小幅下降1.3个百分点。经营活动所得现金净额35.88亿元，同比增幅超过10倍。销售及市场推广费用为31.84亿元，同比增长36.7%，占总收入的36.9%。管理等开支3.47亿元，同比提升16.1%，持续精细化控制下经营效率进一步优化。本期公司产品收入82.01亿元，占总收入比重达95%以上，较上年同期增长56.7%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"信达生物2026年中期营收86.18亿元，经调整净利润17.04亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670365022","title":"信达生物(01801)：捷帕力®(匹妥布替尼)在中国获批慢性淋巴细胞白血病(CLL)╱小淋巴细胞淋巴瘤(SLL)全线治疗新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2670365022","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670365022?lang=zh_cn&edition=full","pubTime":"2026-09-28 18:14","pubTimestamp":1790590452,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信达生物 发布公告，已上市的非共价(可逆)布鲁顿酪氨酸激酶抑制剂捷帕力正式获得中国国家药品监督管理局批准新增适应症，单药适用于全线治疗慢性淋巴细胞白血病╱小淋巴细胞淋巴瘤成人患者。两项研究共同支持了匹妥布替尼在CLL/SLL全治疗线患者中的临床价值。BR是目前用于CLL治疗的一种化学免疫治疗方案。在CLL/SLL患者中，肿瘤细胞主要存在于外周血中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"信达生物(01801)：捷帕力®(匹妥布替尼)在中国获批慢性淋巴细胞白血病(CLL)╱小淋巴细胞淋巴瘤(SLL)全线治疗新适应症","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0502904849.HKD","LU2097828557.USD","LU0607220059.USD","LU1969619763.USD","LU2097828805.USD","LU2097828474.EUR","LU0244354667.USD","01801","LU2242644610.SGD","LU2488822045.USD","LU0455707207.USD","KURE","LU2097828631.EUR","LU0149534421.HKD","LU1831875114.USD","HK0000165453.HKD","BK1161","BK1589","LU2328871848.SGD","BK1583","LU2097828714.EUR","LU1188198961.HKD","LU0326950275.SGD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670228562","title":"港股三大指数早盘涨跌不一 恒生指数半日涨0.64% 网易（09999）涨4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670228562","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670228562?lang=zh_cn&edition=full","pubTime":"2026-09-28 12:15","pubTimestamp":1790568904,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数早盘涨跌不一，截至午间收盘，恒生指数上涨0.64%；国企指数上涨0.57%；恒生科技指数下跌0.54%。板块方面，港股人工智能板块表现强势，截至午间收盘，科拓股份涨24.4%，白鸽在线涨4.62%，网易涨4.42%，均胜电子涨3.84%。1）供应方面，碳酸锂产量预计保持小幅增长态势。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/YjFmNjZjNDg2MTA4NTI1ODgwMzI4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YjFmNjZjNDg2MTA4NTI1ODgwMzI4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992619","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930227.SGD","LU2272731782.SGD","03115","LU1935042991.SGD","LU0205439572.USD","688347","LU1439103000.SGD","LU2403377893.USD","BK4588","IE00BYXW3230.USD","LU0405327494.USD","LU2433249047.HKD","LU2458330169.SGD","IE00B1XK9C88.USD","03037","00836","CMAG","LU2746668461.USD","NULC","LU0964807845.USD","LU2430703095.HKD","SG9999014674.SGD","LU0823414551.USD","LU1923622614.USD","IETC","09999","LU0965509283.SGD","IE00B19Z9505.USD","LU0315179316.USD","LU0708994859.HKD","LU1328615791.USD","LU0265550359.USD","LU1280957306.USD","LU0823413660.USD","IE00B19Z8X17.USD","IE00BKDWB100.SGD","LU2244417387.USD","SG9999018857.SGD","LU0308772762.SGD","LU0348788117.USD","LU0455707207.USD","NVDA","ABFL","HK0000914686.HKD","SG9999014567.USD","601857","LU0264606111.USD","LU0417516902.SGD","SPTE","LU1993786604.SGD","LU0210533765.USD","LU1642822529.SGD","SG9999001051.SGD","LU1983260115.SGD","2NVD.UK","LU1066053197.SGD","LU0719512351.SGD","LU0545039389.USD","LU0868494708.USD","CHPX","LU2097344357.USD","LU0348783662.USD","LU1035773651.USD","NVIW.SI","LU0056508442.USD","LU2361045086.USD","82800","LU0345770308.USD","LU1815333072.USD","LU1166156734.SGD","LU2347655156.SGD","LU1202635105.USD","LU2097344431.USD","SNVDAmain","LU1282651048.USD","LU0323591593.USD","LU2473716301.USD","LU0788109477.HKD","IE00B29SXG58.USD","LU1066051811.HKD","SG9999014575.USD","SG9999004303.SGD","ARTY","LU1961090484.USD","LU0588545730.USD","LU0543330483.HKD","LU0821914370.USD","IE00B775H168.HKD","SGXZ86797644.SGD","LU0106959298.USD","LU0868486357.SGD","TEK","XLK","LU2097828631.EUR","LU2361044865.SGD","LU0359202008.SGD","LU1211504680.USD","LU1366192091.USD","LU1868836591.USD","LU0289960550.SGD","IE0004086264.USD","LU2047632596.USD","BK4532","IE00BDCRKT87.USD","LU0345769631.USD","LU1400636491.USD","LU1935042488.USD","IE0009G5SDU7.USD","IE00BQXX3D17.EUR","LU0225283273.USD","LU0238689110.USD","LU0170899867.USD","BK1594","AGOX","CRPJY","HHImain","LU1923623000.USD","IXN","IE00B1BXHZ80.USD","LU0353189680.USD","LU2168564065.EUR","GB00BDT5M118.USD","LU1066051498.USD","SMH","TCHI","LU0138981039.USD","LU0315178854.USD","ESLG","IE00BWDBJ730.SGD","LU2394011477.USD","LU0203201768.USD","LU0143551892.USD","LU0795875169.SGD","LU0080751232.USD","LU1785774172.SGD","HK0000306701.USD","LU2458330243.SGD","LU0353189763.USD","LU1769817096.USD","LU2088748020.USD","IE000W1ABFV2.USD","LU0516423174.USD","LU2293587155.HKD","LU0345769128.USD","LU0328353924.USD","LU1102505929.USD","NVDS.UK","LU0228659784.USD","LU0472753341.HKD","NVII","LU1839511570.USD","VT","LU1634259391.SGD","LU1481107354.HKD","LU0650527681.SGD","LU2756315318.SGD","THMR","SHOC","NVDO","LU1226288253.USD","LU0029864427.USD","LU1316542783.SGD","LU1989772923.USD","07388","LU2213496289.HKD","NVDX","600699","HK0000320223.HKD","LU1497733631.SGD","LU1917777945.USD","SOXX","TRFK","LU2054465674.USD","SG9999006597.SGD","LU0823413587.USD","LU0605514214.HKD","02319","LU0417516571.SGD","LU1144417596.USD","LU1267930573.SGD","SG9999015978.USD","00699","NVYY","IE00BKPKM429.USD","BK4587","LU0039217434.USD","3NVD.UK","LU0109392836.USD","LU0348784397.USD","LU0516422952.EUR","LU1969619763.USD","LU2471134523.USD","IE00B3S45H60.SGD","SG9999014559.SGD","SG9999015341.SGD","LU2506951792.HKD","BK4598","LU0471298777.SGD","LU1435385759.SGD","LU2286300806.USD","SG9999003461.SGD","ILDR","09696","LU0048580855.USD","LU0868494617.USD","LU2294711713.HKD","LU0898667661.SGD","LU1551013425.SGD","03033","BK1530","LU0823414478.USD","CHAT","IE000KEQY171.SGD","LU1989772840.SGD","LU0347712357.USD","BK4549","LU2592432038.USD","02272","SG9999015952.SGD","LU0611395673.USD","LU0124676726.USD","LU0456846285.SGD","BK1170","DIPS","LU0029875118.USD","LU0210527791.USD","LU0348735423.USD","LU0354030438.USD","LU0553294199.USD","300750","LU2491050071.SGD","LU0329678337.USD","IE0009570106.USD","LU1515016050.SGD","LU0708995401.HKD","LU1813983027.USD","LU2051468812.USD","LU1035775433.USD","LU0109391861.USD","NVDL","09388","LU0345768740.USD","LU0516423091.SGD","LU1066051225.USD","LU0965509010.AUD","LU0502904849.HKD","FAI","LU0094547139.USD","BK4141","300568","CIADY","LU2045819591.USD","LU0957791311.USD","LU2413666699.HKD","LU2430703251.USD","LU2242644610.SGD","LU2125909759.SGD","LU1688375341.USD","LU2452424414.USD","SGXZ99366536.SGD","LU0310800965.SGD","LU0501845795.SGD","LU2088747998.USD","SOXY","LU0107464264.USD","LU1880398554.USD","LU0251143458.SGD","LU2125909916.SGD","LU0640798160.USD","LU1226287792.SGD","82828","LU0342679015.USD","BK4550","LU0594300179.USD","LU1244550494.USD","LU2931357623.SGD","LU2360106780.USD","LU0320764755.SGD","LU1232071149.USD","KWEB","LITP","LU2552382132.HKD","LU2954938101.SGD","LU0516422440.USD","LU0348805143.USD","LU0061475181.USD","LU1720050803.USD","BK1615","LU1923622291.USD","LU0187121727.USD","SG9999017495.SGD","IE00BD6J9T35.USD","LU0348723411.USD","LU0048584097.USD","LU0203202063.USD","HK0000304797.USD","LU1116320901.HKD","SGXZ51526630.SGD","LU1303224171.USD","NTES","LU0326950275.SGD","688981","LU0943347566.SGD","LU2361044949.HKD","LU1188198961.HKD","LU2111349929.HKD","LU1623119135.USD","LU2279701549.SGD","IE0003U64NQ7.SGD","LU3102509885.SGD","03750","BK1553","LU0880133367.SGD","SG9999004220.SGD","LU0210536198.USD","LU2168564495.EUR","IE00BZ1G4Q59.USD","LU1732800096.USD","07588","IE0034235295.USD","80992","LU0154236417.USD","LU1152091754.HKD","LU1880383440.USD","LU2089985449.USD","SG9999014906.USD","BK1116","AIFD","BK1526","LU0173614495.USD","LU0738911758.USD","LU1153585028.USD","LU1366333091.USD","LU2092627202.USD","LU0494093205.USD","09067","LU2100268510.USD","LU2322448957.HKD","LU0737861699.HKD","00992","LU1496350171.SGD","LU0476273544.USD","LU1719994722.HKD","LU1868837136.USD","LU2476274720.SGD","BNGE","IE00BKVL7J92.USD","BK4608","IE00B031HY20.USD","LU0117841782.USD","LU0737861772.HKD","LU1261432733.SGD","LU1791710582.SGD","BK1161","BK4592","LU0256863811.USD","LU0651946864.USD","LU2463028550.USD","LFGY","LU2168563687.JPY","01109","LU0823434583.USD","HK0000914660.USD","SG9999000418.SGD","02498","03032","LU0051755006.USD","LU2543165471.USD","LU0049112450.USD","LU1732799900.SGD","LU1051768304.USD","LU2097828805.USD","SG9999009997.SGD","FDTX","LU0096362180.USD","IE0003895053.USD","LU0106261372.USD","HSTECH","LU0633140560.USD","LU0557290698.USD","00981","CLSE","LU0786609619.USD","LU2237443382.USD","NVDU","SG9999015986.USD","LU2211815571.USD","09788","LU2461242641.AUD","LU2637965513.SGD","02800","IE00BDRTCR15.USD","06067","LU1804176565.USD","WISE","LU0234572021.USD","LU0417517546.SGD","IE00B5949003.HKD","LU1645745479.HKD","LU2097828714.EUR","LU1935042215.USD","LU2250418816.HKD","IE000Q6AESB8.SGD","LU1720051017.SGD","LU2237443549.SGD","LU2272731865.HKD","01801","SG9999014898.SGD","LU1224709979.USD","IE00B19Z5X02.USD","LU2191332357.HKD","IE00BQXX3C00.GBP","IE0004445015.USD","LU0588545490.SGD","LU2552382215.SGD","LU0106252389.USD","CRBJY","HK0000304805.HKD","LU0354030511.USD","LU0431992006.USD","IE00B775SV38.USD","LU0672654240.SGD","BK1104","LU0823421333.USD","LU1808992512.USD","LU0158827781.USD","LU0640476718.USD","GAMR","NVD3.UK","NVDG","NVDS","LU0061474960.USD","LU2756315664.SGD","LU2023250504.SGD","IE00B5TLWC47.USD","IE00BK4W5L77.USD","LU2089283258.USD","LU2778985437.USD","IE00B3SWFQ91.USD","LU2065171402.SGD","LU1145028129.USD","USXF","IE00BQJZWZ67.USD","BK1597","LU1815336760.USD","IE00BJTD4N35.SGD","LU1979441026.SGD","LU2491050154.USD","LU0820562030.AUD","LU1429558221.USD","LU0072462343.USD","LU0965509101.SGD","BK1607","HSI","IE0003851619.USD","LU0231483743.USD","LU1989764664.SGD","NVDW","LU2092937148.SGD","LU0972618739.USD","LU2326559502.SGD","LU2462591277.SGD","LU0456827905.SGD","LU0561508036.HKD","BK1614","LU1852331112.SGD","IE0004445239.USD","LU0385154629.USD","LU1992135472.HKD","NVDQ","BK1531","LU1226287529.USD","LU0683600562.USD","IE0034235188.USD","LU1868836914.USD","02382","513600","BK4551","LU1803068979.SGD","SGXZ62798434.SGD","07226","BK4612","LU2471134879.HKD","LU2028103732.USD","LU2125154935.USD","IE00BMPRXN33.USD","LU0738912210.USD","LU0057025933.USD","BK1570","IE00BMPRXR70.SGD","SG9999002232.USD","LU1674673428.USD","LU0072913022.USD","LU0405327148.USD","LU0784639295.USD","LU1803068623.USD","02465","LU0642271901.SGD","LU0395794307.EUR","LU2133065610.SGD","BK1588","ESUM","LU0082616367.USD","BK1528","LU0323239441.USD","LU0345768153.USD","LU0861579265.USD","LU0211327993.USD","LU0965508806.USD","LU2357305700.SGD","SG9999015358.SGD","LU2487616109.SGD","IE00BJTD4V19.USD","LU1244550577.SGD","LU0823426480.USD","02672","LU2999663052.SGD","IE00B031J352.USD","LU0675040207.SGD","LU1048596156.SGD","LU2125909593.SGD","IE00BWXC8680.SGD","LU1951200564.SGD","LU0163747925.USD","LU2077746001.SGD","MCHmain","LU1242518931.SGD","LU2087625088.SGD","LU0572939691.SGD","BK4543","LU0211977185.USD","LU1226288170.HKD","LU0516422366.SGD","LU3063872942.SGD","AIPI","LU2237443622.USD","LU2237443978.SGD","LU0164865239.USD","LU1960683339.HKD","LU2088747725.USD","IE00BN29S564.USD","VGT","IE00B4YYXB79.USD","LU0702159343.USD","LU0871576103.HKD","LU1235295612.USD","LU0588546209.SGD","LU2328871848.SGD","HK0000819398.USD","LU0228367735.SGD","BK1610","BK1119","LU2505996509.AUD","03067","LU1008478684.HKD","LU2237438978.USD","LU2322448791.USD","BK4548","LU0469268626.HKD","LU0689626769.HKD","07788","LU0006306889.USD","LU0310800379.SGD","LU1323610961.USD","09088","LU2462157665.USD","LU0540923850.HKD","IE0003795394.USD","IE00BSNM7G36.USD","LU2746668974.SGD","IE00B19Z8W00.USD","IE00B97KM107.HKD","LU1868836757.USD","NVC","LU1226288097.SGD","LU0052750758.USD","HK0000165453.HKD","IE00BQXX3F31.USD","LU1914381329.SGD","LU2491049909.HKD","SG9999010052.SGD","LU2750360997.AUD","LU0287142896.SGD","LU0310799852.SGD","02828","LU1069344957.HKD","FTEC","LU2083900584.USD","LU0672654166.SGD","BK4579","07200","03423","LU1778281490.HKD","LU1721428933.USD","LU2381873111.SGD","LU2420271590.USD","LU1629891620.HKD","LU1934455194.USD","LU2272731600.USD","LU2896262040.SGD","03416","LU1366334651.USD","HK0000532082.HKD","IE0008369823.USD","LU0528227936.USD","LU1675838814.USD","LU1712237335.SGD","LU1116320737.USD","LU2264538146.SGD","LU0053666078.USD","LU0594300419.USD","BK1110","LU1674673691.USD","LU0256863902.USD","IE00B0JY6N72.USD","LU0251144936.SGD","LU1023057109.AUD","IE000ITXATA3.USD","IE0004091025.USD","LU2242649171.HKD","LU1282651121.HKD","BK1163","LU0345770993.USD","LU2456880835.USD","IE00BFSS7M15.SGD","LU0077335932.USD","LU0323240290.USD","LU0877626530.USD","LU1119994496.HKD","SGXZ80539844.SGD","BK1609","IE00B4JS1V06.HKD","LU0607220059.USD","BK4581","IE00BZ199S13.USD","LU0414403682.SGD","FDNI","BK4554","LU1691799644.USD","LU1992135399.USD","NVD2.UK","IE00BJJMRY28.SGD","LU0898699433.AUD","LU1880398471.USD","07288","LU2750360641.GBP","LU0234570918.USD","LU1868837300.USD","LU0127658192.USD","LU1497734951.SGD","LU0985320562.USD","BK1504","LU2125909247.SGD","LU0314109678.HKD","SOXQ","LU0149721374.USD","LU2168564149.EUR","LU0957808578.USD","LU1634259557.SGD","BK1509","LU0572944931.SGD","LU2125154778.USD","IE00B067MR52.USD","LU2602419157.SGD","LU2065169927.USD","LU1003077747.HKD","LU1770034418.SGD","LU2265009873.SGD","IE00BZ08YS42.EUR","LU0149534421.HKD","LU0211328371.USD","LU0316494557.USD","LU2360107168.USD","LU0188438112.USD","SG9999014880.SGD","SGXZ81514606.USD","LU2505996681.GBP","LU0174119429.USD","LU0823426308.USD","LU1522347837.USD","01772","LU0251132253.USD","LU1497733557.USD","09115","LU1655091459.SGD","LU1037948897.HKD","LU1069347547.HKD","LU0061474705.USD","IE00BHPRN162.USD","LU1633808545.USD","IE0001KFT4U8.USD","LU0683595622.HKD","LU1814569148.SGD","LU1951186391.HKD","LU1831875114.USD","LU2023251221.USD","LU1935043536.SGD","LU0267386448.USD","LU1037948541.HKD","BK4503","LU0164880469.USD","LU0140636845.USD","LU0293314216.USD","BK1583","03088","LU0052756011.USD","IE00BMPRXQ63.HKD","LU2347655073.USD","TYLG","BK1195","BK1539","LU1084165304.USD","LU1935043452.HKD","LU0390134368.USD","LU0175139822.USD","LU0266013472.USD","BK4529","LU1267930730.SGD","BK1193","LU0192582467.USD","IE00B3M56506.USD","IE00BZ08YT58.USD","USD","IE0009356076.USD","LU2290526834.HKD","LU1152091168.USD","LU1988902786.USD","SG9999018865.SGD","LU0828237510.HKD","LU0820561818.USD","LU0169518387.USD","83115","LU0890818403.SGD","LU0787776722.HKD","CNEQ","LU2471134796.USD","07300","LU0289961442.SGD","LU2430703178.SGD","METV","LU2148611432.USD","LU2087621335.USD","LU0329678170.USD","SG9999011746.SGD","SMHX","IE00BFSS8Q28.SGD","IE0005OL40V9.USD","LU1807302812.USD","LU2088748376.SGD","LU2271345857.HKD","LU0117844026.USD","LU2860962120.EUR","SG9999002224.SGD","LU1115378108.SGD","LU0133085943.USD","LU0942090050.USD","IE00B7KXQ091.USD","LU1251922891.USD","LU2097828557.USD","LU0158827948.USD","HSCEI","LU0417516738.SGD","LU0072462426.USD","LU0862451837.USD","LU1102505762.USD","LU1400636574.HKD","02802","BK1521","LU1496350502.SGD","LU0067412154.USD","03419","JGRO","LU1046422090.SGD","LU1328277881.USD","LU0276348264.USD","LU0572940350.SGD","BK1226","IE0031814852.USD","LU1064131342.USD","BK1592","00857","LU0661504455.SGD","02833","LU0370786039.SGD","LU0823434740.USD","LU0265550946.USD","LU1880383366.USD","LU2360032135.SGD","LU2462591350.SGD","SG9999014914.USD","LU0889565833.HKD","LU2257852520.SGD","LU1242518857.USD","LU1548497426.USD","NVDY","LU0210526637.USD","IE000YTNTUN2.SGD","LU0157215616.USD","LU1861127337.USD","LU2089284900.SGD","002460","LU0791591158.USD","LU0820561909.HKD","LU1718418525.SGD","LU0791590937.USD","LU1720051108.HKD","LU2097828474.EUR","LU2413666426.HKD","LU2108987350.USD","BK1555","LU0823421416.USD","LU0588545904.SGD","LU2279689827.SGD","LU0359201612.USD","SNPE","02238","SNVD.UK","02837","BK1240","LU2088748293.HKD","BK4614","LU0348783233.USD","TTEQ","LU1861220033.SGD","LU1791710400.SGD","IE00BK4W5M84.HKD","TTXU","BK4533","LU0862451753.SGD","LU1551013342.USD","IE00BZ08YR35.GBP","002466","LU1670756490.USD","LU2237957811.SGD","LU0048597586.USD","LU0634319403.HKD","LU1206782309.USD","07552","BK1237","LU0259732245.USD","LU0795875086.SGD","SG9999014542.SGD","LU1734074674.USD","LU0633140727.USD","LU2476274308.USD","01347","LU0128522157.USD","ANV","IE0032431581.USD","LU2247934214.USD","NVD","IE0032834883.USD","IE00B0169L03.USD","LU1951198990.SGD","LU0348827113.USD","IE00BJJMRX11.SGD","BK4567","SG9999015945.SGD","LU0049853897.USD","LU1699723380.USD","LU2236285917.USD","LU2242650005.HKD","LU1571399168.USD","SGXZ31699556.SGD","LU0444973449.USD","LU0081259029.USD","LU0096364046.USD","LU1366334578.USD","LU0198837287.USD","LU2065171311.SGD","LU0320764599.SGD","LU2152927971.USD","BK1129","LU2249611893.SGD","SG9999010078.USD","BK1589","LU1769817179.HKD","LU1226287875.USD","LU0215105999.USD","LU2237443465.HKD","SG9999001093.SGD","LU1794554557.SGD","LU0210528500.USD","LU1048588211.SGD","LU0708995583.HKD","SG9999001846.SGD","BK4605","LU1119993845.HKD","LU0348825331.USD","HK0000306685.HKD","LU0181495838.USD","LU1244550221.USD","LU1861215975.USD","LU0882574139.USD","LU0593848301.USD","ROM","KURE","07500","LU0724617625.USD","LU0327786744.USD","LU2237957902.USD","LU2488822045.USD","LU0702159699.USD","LU1400636657.SGD","EFIV","LU2417539215.USD","SGXZ23171101.USD","BK1125","LU0128525689.USD","LU2399975544.HKD","LU2023250330.USD","LU1934455277.USD","LU1974910355.USD","LU0128525929.USD","SG9999001424.SGD","LU0079474960.USD","LU0865486749.SGD","LU1127390331.HKD","BK4534","BK1190","LU0444971666.USD","LU0441854154.USD","LU0070217475.USD","LU0466842654.USD","LU0979878070.USD","NVDB","LU0274383776.USD","LU0912757837.SGD","LU0511384066.AUD","LU2357125470.USD","BK1179","HK0000320264.USD","IE0034224299.USD","LU2065170008.USD","LU2471134952.CNY","LU2552382058.USD","NVDD","LU1935043023.USD","LU0689472784.USD","LU0097036916.USD","LU2237443895.HKD","LU0289739343.SGD","BK4527","LU0307460666.USD","LU1989764748.USD","LU0463099449.HKD","03417","BK1144","IE00BJLML261.HKD","LU0726765562.USD","LU1821325948.USD","LU0359201885.HKD","LU0244354667.USD","LU1267930490.SGD","LU2168564222.USD","BK1608","IE0008368742.USD","LNVGY","BK4585","LU0531971595.HKD","603906","LU0831103253.SGD","LU1224444064.USD","LU1934455863.HKD","LU0011850046.USD","LU0320765059.SGD","LU2039709279.SGD","LU2063271972.USD","LU2125910500.SGD","SG9999002828.SGD","IE0034235303.USD","LU2106854487.HKD","LU0949170772.SGD","LU0069063385.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168375102","title":"异动解读｜信达生物盘中下跌3.31%，报96.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375102","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168375102?lang=zh_cn&edition=full","pubTime":"2026-09-28 10:08","pubTimestamp":1790561298,"startTime":"0","endTime":"0","summary":"9月28日，信达生物盘中下跌3.31%，报96.4港元/股，成交额1.51亿港元。信达生物所在的生物科技行业中，板块表现分化，个股中，康方生物跌1.82%，百济神州涨1.39%，康希诺生物涨3.69%，荣昌生物跌0.82%，三生制药跌0.81%。信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢、自身免疫及眼科等重大疾病创新药物的投资控股公司，药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innoventbio.com","stockEarnings":[{"period":"1week","weight":-0.0389},{"period":"1month","weight":-0.0537},{"period":"3month","weight":0.0011},{"period":"6month","weight":-0.0268},{"period":"1year","weight":0.0034},{"period":"ytd","weight":0.1679}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢（CVM）、自身免疫及眼科等重大疾病创新药物的投资控股公司。药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。该公司的主要产品包括达伯舒（信迪利单抗注射液）、达攸同（贝伐珠单抗注射液）、苏立信（阿达木单抗注射液）、达伯华（利妥昔单抗注射液）、达伯坦（佩米替尼片）等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.041076},{"month":2,"riseRate":0.75,"avgChangeRate":0.110526},{"month":3,"riseRate":0.25,"avgChangeRate":-0.01934},{"month":4,"riseRate":0.75,"avgChangeRate":0.043223},{"month":5,"riseRate":0.375,"avgChangeRate":0.014737},{"month":6,"riseRate":0.625,"avgChangeRate":0.116146},{"month":7,"riseRate":0.5,"avgChangeRate":0.019948},{"month":8,"riseRate":0.75,"avgChangeRate":0.024842},{"month":9,"riseRate":0.5,"avgChangeRate":0.021235},{"month":10,"riseRate":0.25,"avgChangeRate":-0.031476},{"month":11,"riseRate":0.625,"avgChangeRate":0.079172},{"month":12,"riseRate":0.375,"avgChangeRate":0.024026}],"exchange":"SEHK","name":"信达生物","nameEN":"INNOVENT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信达生物,01801,信达生物股票,信达生物股票老虎,信达生物股票老虎国际,信达生物行情,信达生物股票行情,信达生物股价,信达生物股市,信达生物股票价格,信达生物股票交易,信达生物股票购买,信达生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}